Add-back therapy and gonadotropin-releasing hormone agonists in the treatment of patients with endometriosis: can a consensus be reached?

Condition tags

MeSH descriptors

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (20)

• Administration of Nasal Nafarelin as Compared with Oral Danazol for Endometriosis via openalex
• Can hormone replacement therapy be used during medical therapy of endometriosis? via openalex
• Effectiveness of tibolone on hypoestrogenic symptoms induced by goserelin treatment in patients with endometriosis via openalex
• Hormone treatment of endometriosis: The estrogenthreshold hypothesis via openalex
• Is It Possible to Prevent Bone Loss in Young Women Treated with Luteinizing Hormone-Releasing Hormone Agonists? via openalex
• Leuprolide Acetate Depot and Hormonal Add-Back in Endometriosis: A 12-Month Study via openalex
• Lupron depot (leuprolide acetate for depot suspension) in the treatment of endometriosis: a randomized, placebo-controlled, double-blind study via openalex
• Medroxyprogesterone acetate supplementation diminishes the hypoestrogenic side effects of gonadotropin-releasing hormone agonist without changing its efficacy in endometriosis via openalex
• Prolonged gonadotropin-releasing hormone agonist treatment of symptomatic endometriosis: the role of cyclic sodium etidronate and low-dose norethindrone “add-back” therapy via openalex
• Reduction of vasomotor symptoms and bone mineral density loss with combined norethindrone and long-acting gonadotropin-releasing hormone agonist therapy of symptomatic endometriosis: a prospective randomized trial. via openalex
• The effects of combining norethindrone with a gonadotropin-releasing hormone agonist in the treatment of symptomatic endometriosis via openalex
• The effects of combining norethindrone with a gonadotropin‐releasing hormone agonist in the treatment of symptomatic endometriosis via openalex
• Treatment of endometriosis with a long-acting gonadotropin-releasing hormone agonist plus medroxyprogesterone acetate. via openalex
• Zoladex (goserelin acetate implant) in the treatment of endometriosis: a randomized comparison with danazol. The Zoladex Endometriosis Study Group. via openalex
• W6717624033 via openalex
• W133578770 via openalex
• W201040832 via openalex
• W2004430776 via openalex
• W2123876576 via openalex
• W2342833836 via openalex

Cited by (50)

• Weighing up GnRH agonist therapy for endometriosis: outcomes and the treatment paradigm 2025
• Pharmacokinetic considerations for gonadotropin-releasing hormone agonists and antagonists to treat endometriosis 2025
• Horizons in Endometriosis: Proceedings of the Montreux Reproductive Summit, 14-15 July 2023 2024
• The Double Engines and Single Checkpoint Theory of Endometriosis 2022
• Interdisciplinary model‐informed drug development for extending duration of elagolix treatment in patients with uterine fibroids 2022
• A Preliminary Study on the Effects of Black Cohosh Preparations on Bone Metabolism of Rat Models With GnRH-a-Induced Peri-Menopausal Symptoms 2022
• Role of medical treatment of endometriosis 2021
• Endometriosis 2021
• Endometriose Aspectos clínicos do diagnóstico ao tratamento 2021
• Neue Behandlungsmöglichkeiten der Endometriose mit GnRH-Antagonisten 2020
• Neue Behandlungsoptionen mit GnRH-Antagonisten bei Endometriose und Uterus myomatosus 2020
• Tolerability considerations for gonadotropin-releasing hormone analogues for endometriosis 2020
• Endometriosis 2019
• Long-term medical management of endometriosis with dienogest and with a gonadotropin-releasing hormone agonist and add-back hormone therapy 2017
• Initiation of GnRH agonist treatment on 3-5 days postoperatively in endometriosis patients: a randomized controlled trial 2015
• Treatment of Endometriosis with the GnRHa Deslorelin and Add-Back Estradiol and Supplementary Testosterone 2015
• The effect of macrophages on fibroblast activity and lesion development in mouse models of endometriosis. 2014
• The incidence and characteristics of uterine bleeding during postoperative GnRH agonist treatment combined with estrogen-progestogen add-back therapy in endometriosis patients of reproductive age. 2013
• Endometriose 2013
• PENATALAKSANAAN ENDOMETRIOSIS 2012
• The Hormonal Profile of Norethindrone Acetate: Rationale for Add-Back Therapy With Gonadotropin-Releasing Hormone Agonists in Women With Endometriosis 2012
• Endometriosis 2012
• Quality of life according to add-back therapy during GnRH agonist treatment in endometriosis patients 2012
• Clinical Management of Endometriosis 2011
• Gonadotropin releasing hormone agonists: Expanding vistas 2011
• Evidence-based long-term management of endometriosis: Medical therapy and treatment of infertility 2011
• The efficacy and tolerability of short-term low-dose estrogen-only add-back therapy during post-operative GnRH agonist treatment for endometriosis 2010
• Gonadotropin-releasing hormone agonist and add-back therapy: what do the data show? 2010
• Add-back therapy use and its impact on LA persistence in patients with endometriosis 2010
• Chronic pelvic pain and endometriosis: translational evidence of the relationship and implications 2010
• Immediate and delayed add‐back hormonal replacement therapy during ultra long GnRH agonist treatment of chronic cyclical pelvic pain 2009
• GnRH-Analoga und Add-back-Verfahren 2008
• Patientinnenzentrierte Aspekte der Endometriose 2008
• Endometriose 2007
• Endometriosis and Adenomyosis 2007
• Endometriosis 2007
• Bone Density in Adolescents Treated with a GnRH Agonist and Add-Back Therapy for Endometriosis 2007
• Tratamento da endometriose 2006
• The incidence and characteristics of uterine bleeding during postoperative GnRH agonist treatment combined with tibolone add-back therapy in endometriosis patients of reproductive age 2006
• Is it of value to treat endometriosis prior to IVF 2006
• Long-term fracture risk among women with proven endometriosis 2006
• Evaluation and Management of Breast Pain 2004
• Add-back therapy in the treatment of endometriosis-associated pain 2004
• Novel targets for the treatment of endometriosis 2004
• One year comparison between two add-back therapies in patients treated with a GnRH agonist for symptomatic endometriosis: a randomized double-blind trial 2004
• Medikamentöse und konservative Therapie 2004
• Patientinnenzentrierte Aspekte der Endometriose 2003
• Medical Therapy for Endometriosis 2003
• Endometriosis: Treatment Strategies 2003
• Evaluation and management of women with endometriosis 2003

Source provenance

europepmc

last seen: 2026-06-04T01:30:01.192114+00:00

openalex

last seen: 2026-06-10T17:14:06.276822+00:00

pubmed

last seen: 2026-05-13T22:10:29.640636+00:00